(Total Views: 640)
Posted On: 03/25/2022 2:06:57 PM
Post# of 153932
I normally don't look at SA, but here's the part that you'd be interesting in reading:
Quote:
Major drug companies, including leading COVID-19 vaccine developers, have joined efforts to discover a potential treatment for long COVID, a condition affecting over 100 million people globally, according to the World Health Organization (WHO).
Long COVID is marked by hundreds of different symptoms such as fatigue, chest pain, and brain fog lasting more than three months. It affects people who had both mild and severe COVID-19, including children.
Leading developers of COVID-19 vaccines and therapeutics are in the early discussions with scientists on how to address the disease, which affects an estimated 1-in-7 working-age adults, according to Reuters.
.
.
.
In June, CytoDyn (OTCQB:CYDY) shared interim data from its COVID-19 long-haulers clinical trial, which, according to the company, showed an improvement of most of the symptoms compared to a placebo.
(3)
(0)
My comments are just my opinions and should NOT be taken as investment advice.
